Puzzling trading activity in the marijuana sector may be related to exchange-traded fund (ETF) action, says an analyst in the space.

On Tuesday (August 13), 420 Investor analyst Alan Brochstein wrote a note to investors indicating that the ETFMG Alternative Harvest ETF (ARCA:MJ) performed a rebalancing of its holdings last Friday (August 9). He said the move may have led to a spike in share price value for embroiled Canadian producer CannTrust Holdings (NYSE:CTST,TSX:TRST).


Approximately 20 minutes before Friday’s trading session finished, the Canadian cannabis producer surged 40 percent to close at US$3.23 in New York and C$4.21 in Toronto.

“Beyond the irresponsibility of doing such large trades late in the afternoon on a summer Friday, one must question the wisdom of adding to CannTrust, given the issues that the company is facing,” Brochstein wrote.

Despite his criticism, the analyst explained that the fund didn’t pick up CannTrust as a “fundamental decision,” but rather because it was following its mandate of tracking the index it is based upon: the Prime Alternative Harvest Index.

As of Tuesday, CannTrust was among the 10 top weighted companies in the Prime Alternative Harvest Index, with a weight of 4.03 percent.

According to a report from Bloomberg, the ETF added 5.5 million shares of the struggling producer. Brochstein indicated that the company now holds a 3.8 percent weighting in the fund.

CannTrust’s share price increase vanished on Monday (August 12) as the company confirmed that a second of its facilities, its manufacturing operation in Vaughan, Ontario, has been deemed non-compliant by Canadian regulators.

Since Friday, the ETF has risen in value by 1.3 percent to a price of US$28.92 as of Tuesday’s closing bell.

The market for US-based cannabis ETFs has been on the rise as more fund providers seek to offer investors exposure to the marijuana market.

However, these funds can’t yet offer exposure to marijuana operations directly in the US. This is due to the federal illegality of the drug in the US, which forces companies to seek listings in Canada.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less